Medicare Enrolled
Dr. Amin Esfahani, M.D.
Dermatology · Oakdale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Esfahani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Esfahani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Esfahani
Dr. Amin Esfahani is a dermatology specialist in Oakdale, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Esfahani performed 8,241 Medicare services across 3,452 unique beneficiaries.
Between the years covered by Open Payments, Dr. Esfahani received a total of $6,878 from 23 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Esfahani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 12% volume in CA
$6,878 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,241
Medicare services
Top 12% in CA for dermatology
3,452
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~749 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,040 | $5 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,123 | $65 | $217 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
919 | $42 | $165 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
390 | $77 | $268 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
274 | $73 | $265 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
209 | $94 | $306 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
188 | $88 | $293 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
131 | $134 | $418 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
127 | $41 | $135 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
102 | $103 | $619 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
77 | $320 | $1,022 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
63 | $97 | $334 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
60 | $354 | $1,088 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
59 | $294 | $781 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
56 | $1 | $10 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
55 | $118 | $697 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $32 | $136 |
| Light therapy to destroy precancerous skin growth A qualified healthcare professional applies light to the skin to destroy precancerous growths. |
45 | $201 | $630 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
41 | $43 | $141 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $114 | $392 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
26 | $194 | $780 |
| Complicated wound repair, trunk, each additional 5 cm or less This procedure involves a complex repair of a wound on the trunk, performed in addition to the primary repair. It covers each additional 5.0 cm or less of wound length. |
26 | $98 | $293 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
25 | $53 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $11 | $34 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
22 | $107 | $637 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
21 | $392 | $1,192 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
19 | $49 | $175 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
16 | $58 | $224 |
| Complicated wound repair, each additional 5 cm or less This code covers the additional work for a complex surgical repair of a wound on the scalp, arms, or legs when the repair extends beyond the initial measurement. It is billed for each incremental 5-centimeter segment added to the primary procedure. |
13 | $107 | $317 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,878
Total received (2018-2024)
Avg $1,146/year across 6 years
Top 23% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,879 (56.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,986 (43.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,038
2023
$1,783
2022
$3,501
2021
$256
2019
$97
2018
$203
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$329
ABBVIE INC.
$245
Incyte Corporation
$168
Regeneron Healthcare Solutions, Inc.
$85
Lilly USA, LLC
$46
E.R. Squibb & Sons, L.L.C.
$45
LEO Pharma Inc.
$25
Organogenesis Inc.
$22
Dermavant Sciences, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$19
UCB, Inc.
$17
Arcutis Biotherapeutics, Inc.
$14
Top 3 companies account for 71.5% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$3,210
ABBVIE INC.
$750
Janssen Biotech, Inc.
$735
Incyte Corporation
$492
GENZYME CORPORATION
$269
Dermavant Sciences, Inc.
$197
AbbVie, Inc.
$185
Arcutis Biotherapeutics, Inc.
$179
Novartis Pharmaceuticals Corporation
$170
Medtronic, Inc.
$139
Sun Pharmaceutical Industries Inc.
$99
Allergan Inc.
$97
AbbVie Inc.
$82
Lilly USA, LLC
$46
E.R. Squibb & Sons, L.L.C.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Amgen Inc.
$31
LEO Pharma Inc.
$25
Organogenesis Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Teva Pharmaceuticals USA, Inc.
$19
Galderma Laboratories, L.P.
$18
UCB, Inc.
$17
Top 3 companies account for 68.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · Absorica LD · Bimzelx · COSENTYX · DUPIXENT · EPIDUO FORTE · HUMIRA · Humira · ICLUSIG · ILUMYA · INTELLIS ADAPTIVESTIM · Ilumya · OPZELURA · Otezla · PURAPLY AM · REMICADE · RINVOQ · SIMLANDI · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · VTAMA · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
12
Per 100K population
2.2
County median income
$79,661
Nearest hospital
OAK VALLEY HOSPITAL DISTRICT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Esfahani is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Esfahani experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Esfahani performed 4,040 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Esfahani receive payments from pharmaceutical companies?
Yes. Dr. Esfahani received a total of $6,878 from 23 companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Esfahani's costs compare to other dermatologists in Oakdale?
Dr. Esfahani's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Esfahani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Oakdale
Browse dermatologists in Oakdale ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology